Building Bridges to Heart Health Campaign Launched in UAE to Drive Cardiovascular Disease Awareness

Press release
Published September 22nd, 2019 - 11:22 GMT

Bayer
Bayer
Highlights
Bayer announced today the launch of its awareness campaign, ‘Building Bridges to Heart Health

Bayer announced today the launch of its awareness campaign, ‘Building Bridges to Heart Health’, to urge the community to adopt preventive measures against cardiovascular diseases (CVD) across the UAE.

The campaign will include a series of screening events, the launch of innovative and artificial intelligence powered diagnostics solutions, as well as medical education to promote better heart health.

Mohamed Galal, Vice President and Head of Bayer Middle East Consumer Health said, “We have a commitment to increase knowledge and awareness around one of the most common causes of mortalities, CVDs. Through the campaign, our underlying objective is to build bridges between healthcare professionals, consumers, caregivers, as well as policy makers amongst others. We will also partner with leading heart and cardiology associations in the region to spread more awareness amongst patients and those at risk of CVDs.”

CVD death rates are on the rise across the UAE, Kuwait, Egypt, and Lebanon, and account for around 38%, 46%, 40%, 47% of total deaths respectively.[1]

Aspirin acts as a blood “thinner” and helps prevent blood clots from forming and helps prevent heart attack and stroke.[2]

In addition, Dr. Ahmed El Sokary, Consultant Intervention Cardiology at the Saudi German Hospital also said, “More people die annually from CVDs than from any cause. We must focus on altering our diets, engage in physical inactivity, stop tobacco and alcohol use, as they are all major risk factors of CVDs. [3] Such campaigns are an integral aspect of reducing the prevalence of CVDs. In the UAE, urgent commitment to CVD prevention from healthcare professionals, policymakers, government and other stakeholders and the promotion of healthy lifestyles, is warranted.”[4]

Prevention has been a longstanding objective of national governments throughout the region to combat the rising trend of cardiovascular diseases. Sponsored awareness campaigns, educational material as well as driving robust nutrition programs have been part of the equation. It is important to understand the underlying elements that help prevention of cardiovascular events.

“Our goal is to build a better, healthier future for people in the region. This will be achieved by the collective efforts in creating a sense of urgency and awareness around CVDs as well as its implications. We have a growing heart disease problem, and our work will help allow individuals to change their behaviors and improve their lives,” noted Galal.

[1] Prevalence of Cardiovascular Disease and Associated Risk Factors among Adult Population in the Gulf Region: A Systematic Review  https://www.hindawi.com/journals/aph/2015/235101/ ; Egypt | WHO | Risk of premature death due to NCDs | http://communitytimes.me/addressing-risks-and-causes-of-heart-disease-i…; | Lebanon | WHO | Risk of premature death due to NCDs | https://www.who.int/nmh/countries/lbn_en.pdf?ua=1

Background Information

Bayer

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion.

Check out our PR service


Signal PressWire is the world’s largest independent Middle East PR distribution service.

Subscribe

Sign up to our newsletter for exclusive updates and enhanced content